AbbVie raises 2025 EPS guidance and signals strong pipeline milestones into 2026 (NYSE:ABBV)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...